Divi’s Laboratories (DIVISLAB) Share Price falls 2.46% as market cap stays near Rs 2.49 lakh crore
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Divi’s Laboratories Share Price was at Rs 9,046.50, down 2.46% from the previous close, while market capitalisation stood at Rs 2,48,982.98 crore. The stock moved lower during the afternoon trade on 14 October 2026, with Divi’s Laboratories Share Price slipping from the day open of Rs 9,319.90 to an intraday low of Rs 9,028. In Univest terms, this is a clear price fall event for a Large Cap company in Healthcare, and the move is relevant because the stock continues to trade at a high valuation versus its sector context. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Divi’s Laboratories Share Price Today, the most useful lens is the price action alongside the company’s earnings quality, valuation multiples and peer positioning. The session opened at the day high, then weakened through the rest of the trade, leaving the close near the lower end of the day’s range. That pattern matters because it shows pressure during the session rather than a brief dip and recovery. The focus stays on what the move says about the stock’s current pricing, not on any fresh event or recommendation.
Divi's Laboratories (DIVISLAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 9,046.5 |
| Previous Close | Rs 9,275 |
| Today's Move | -Rs 228.50 (-2.46%) |
| Open | Rs 9,319.9 |
| High | Rs 9,319.9 |
| Low | Rs 9,028 |
| Market Capitalisation | Rs 2,48,982.98 crore |
| Market Cap Category | Large Cap |
Divi’s Laboratories Share Price opened at Rs 9,319.90, matched the day high at the same level, and later touched a low of Rs 9,028 before last trading at Rs 9,046.50. That placed the stock Rs 228.50 below the previous close of Rs 9,275, or 2.46% lower, in the latest session. The market capitalisation remained Rs 2,48,982.98 crore, keeping Divi’s Laboratories firmly in the Large Cap bracket. For Divi’s Laboratories Share Price Today, the range shows that the stock spent the day below the opening level and near the lower end of the band. On Univest, such a move is best read as a price action update rather than a standalone signal. The day’s trade also shows a narrow top and a wider drift to the low, which is useful for readers watching intraday behaviour. Because no catalyst is provided in the data, the session should be read as a market move first and a company story only through valuation and peer context.
Divi's Laboratories (DIVISLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,48,982.98 crore |
| P/E Ratio | 84.18x |
| P/B Ratio | 13.94x |
| ROE | 16.19% |
| ROCE | 21.51% |
| EPS | Rs 110.18 |
| Book Value Per Share | Rs 665.36 |
| Dividend Yield | 0.32% |
Divi's Laboratories (DIVISLAB) fundamental metrics show P/E 84.18x, P/B 13.94x, ROE 16.19%, ROCE 21.51%. These figures provide context only and are not a buy or sell signal.
Divi’s Laboratories has a market capitalisation of Rs 2,48,982.98 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 84.18x, P/B at 13.94x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.32%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.72x, median ROE of 11.61%, median ROCE of 13.46%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 84.18x |
| Benchmark Median P/E | 31.72x |
| Benchmark Average P/E | 46.74x |
| Benchmark P/E Range | 3.11x to 663.29x |
| Company P/B Ratio | 13.94x |
| Benchmark Median P/B | 2.91x |
| Benchmark Average P/B | 4.27x |
| Company ROE | 16.19% |
| Benchmark Median ROE | 11.61% |
| Benchmark Average ROE | 10.59% |
| Company ROCE | 21.51% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 13.35% |
| Company Market Capitalisation | Rs 2,48,982.98 crore |
| Benchmark Median Market Cap | Rs 821.94 crore |
| Benchmark Average Market Cap | Rs 13,782.64 crore |
Divi's Laboratories (DIVISLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Divi's Laboratories (DIVISLAB) has a P/E ratio of 84.18x, which is above the benchmark median of 31.72x, a difference of +165.38%. On its own, the P/E gap is a valuation reference point, not a trading call.
Divi's Laboratories (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.61%, a difference of +39.45%. Divi's Laboratories (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.46%, a difference of +59.81%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,22,067.01 | 35.09 | 4.91 | 14.85 | 19.11 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,77,974.12 | 80.83 | 19.64 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,13,615.69 | 25 | 4.18 | 19.69 | 21.39 |
| Laurus Labs | LAURUSLABS | 1,11,898.66 | 101.36 | 19.65 | 18.31 | 18.2 |
| Cipla | CIPLA | 1,06,129.96 | 31.88 | 3.06 | 11.83 | 16 |
Divi's Laboratories (DIVISLAB) has a P/E ratio of 84.18x compared with the displayed peer median of 35.09x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 16.19% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Divi's Laboratories (DIVISLAB) has a market capitalisation of Rs 2,48,982.98 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Divi’s Laboratories
- Divi’s Laboratories Share Price fell 2.46% in the latest session and stayed below the opening level.
- The stock is trading at a rich P/E of 84.18 and P/B of 13.94 versus industry medians.
- ROE of 16.19% and ROCE of 21.51% keep the fundamentals relevant for Divi’s Laboratories Share Price analysis.
- Market capitalisation of Rs 2,48,982.98 crore places it well above the industry benchmark median.
- Divi’s Laboratories Stock News remains tied to price action, valuation and peer comparison rather than a stated catalyst.
About Divi’s Laboratories
Divi’s Laboratories operates in Pharmaceuticals & Drugs within the Healthcare sector. The company is known for pharmaceutical manufacturing and serves as a large-scale listed name in the Indian market. Divi’s Laboratories Share Price is often tracked because the business combines scale with return metrics that sit above broad industry medians. The company’s market capitalisation, EPS, book value and dividend yield give readers a compact view of its financial profile. On Univest, this makes Divi’s Laboratories Stock News relevant not only for daily price action but also for longer-term company analysis. The same profile also explains why the stock attracts attention when valuation stays elevated and the share price moves lower in a session.
Track Divi’s Laboratories Share Price on Univest
Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Divi’s Laboratories Share Price on Univest for live share price updates, fundamental ratios and market insights. The same page also helps readers follow Divi’s Laboratories Stock Analysis, Divi’s Laboratories Latest News and Divi’s Laboratories Share Price Today in one place. For a Large Cap pharma company, these details help keep price action and valuation in context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Divi's Laboratories Share Price falling today?
Ans. Divi's Laboratories Share Price was down 2.46% at Rs 9,046.50 versus the previous close of Rs 9,275. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Divi's Laboratories Share Price Today?
Ans. Divi's Laboratories Share Price Today stood at Rs 9,046.50 in the latest trade. The stock moved between Rs 9,319.90 and Rs 9,028 during the day, showing a clear intraday decline.
What does Divi's Laboratories Share Price movement show?
Ans. The movement shows a Rs 228.50 decline from the previous close. For Divi's Laboratories Share Price, the key facts are the opening level, day high, day low and the final trade near the lower end.
Is Divi's Laboratories a Large Cap stock?
Ans. Yes. Divi's Laboratories is a Large Cap company with market capitalisation of Rs 2,48,982.98 crore. That size makes Divi's Laboratories Share Price a major healthcare market move rather than a small stock swing.
How does Divi's Laboratories compare on valuation?
Ans. Divi's Laboratories Share Price trades at a P/E of 84.18 and P/B of 13.94. Those levels are above the same-industry medians of 31.72 and 2.91, placing it in a premium valuation zone.
What do ROE and ROCE mean for Divi's Laboratories Share Price?
Ans. ROE of 16.19% and ROCE of 21.51% show how the company is using equity and capital employed. These return ratios give Divi's Laboratories Share Price stronger fundamental context than price action alone.
What are Divi's Laboratories EPS and book value?
Ans. EPS is Rs 110.18 and book value is Rs 665.36. For Divi's Laboratories Share Price, EPS shows earnings attributable to each share, while book value reflects accounting net worth per share.
What is the dividend yield on Divi's Laboratories Share Price?
Ans. The dividend yield is 0.32%. For Divi's Laboratories Share Price, this is a historical payout measure relative to the current price and should be read alongside valuation and return ratios.
How does Divi's Laboratories compare with peers?
Ans. Divi's Laboratories Share Price has a higher P/E and P/B than Sun Pharmaceutical Industries, Zydus Lifesciences, Cipla and Dr. Reddy's. Its ROE and ROCE are also solid in the listed peer set.
